April 19, 2018
Rose
Novo Nordisk and San Francisco-based Sempre Health have announced their collaboration on a pilot program that will offer diabetes medications through the latter company’s monetary incentive and SMS-driven prescription refill platform. The partnership is hoping to engage 10,000 diabetes patients on Sempre’s platform within 2018.
from MobiHealthNews https://ift.tt/2qNYFjt
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment